Health Condition 1: C19- Malignant neoplasm of rectosigmoidjunction Health Condition 2: C689- Malignant neoplasm of urinary organ, unspecified Health Condition 3: C55- Malignant neoplasm of uterus, partunspecified
Conditions
Interventions
Intervention1: LIDOCAINE INFUSION: AFTER GA, IV LIDOCAINE INFUSION WILL BE STARTED AT THE RATE OF 1.5MG/KG BOLUS OVER 10 MIN, FOLLOWED BY 1 MG/KG/HR TILL END OF SURGERY
Control Intervention1: PLACEBO
Sponsors
Rajiv Gandhi Cancer Institute and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: all adult female patients undergoing major abdominal oncosurgeries
Exclusion criteria
Exclusion criteria: DRUG ALLERGY, PATIENT REFUSAL, ELECTROLYTE IMBALANCE,CARDIAC DISEASE OR ANY CONTRAINDICATION TO THE USE OF IV LIDOCAINE
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TOTAL OPIOID CONSUMPTION, NUMERICAL RATING SCALE FOR PAIN,TIME TO RESCUE ANALGESIA, RECOVERY PROFILETimepoint: T1-END OF SURGERY, T2-T7-2,4,6,8,12,24 HR POST SURGERY | — |
Secondary
| Measure | Time frame |
|---|---|
| TIME TO RETURN OF GI FUNATION, TIME OF ICU DISCHARGE, LA TOXICITY, INCIDENCE OF CHRONIC PAIN AT 3 MONTHSTimepoint: T1-END OF SURGERY, T2-T7-2,4,6,8,12,24 HR POST SURGERY,T8-3 MONTHS POST SURGERY | — |
Countries
India
Contacts
Public ContactDr Mamta Dubey
Rajiv Gandhi Cancer Institute and Research Centre
Outcome results
None listed